High-risk Neuroblastoma
📧 Sign up to get email alerts when something new happens for High-risk Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 [Phase 1]
Phase 1 trial of GD2-SADA:177Lu-DOTA complex for GD2-expressing solid tumors was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma [Phase 1, Phase 2]
This clinical trial update indicates a Phase 1/2 study of dual-target GD2/B7-H3 CAR-NK cells for pediatric relapsed or refractory neuroblast…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma [Phase 2]
Phase 2 trial evaluating dinutuximab with sargramostim and combination chemotherapy for newly diagnosed high-risk neuroblastoma; results hav…